These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 10586060)

  • 1. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
    Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
    J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
    FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
    Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling of type II oncostatin M receptor.
    Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
    Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
    J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
    J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S
    Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
    Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
    Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G
    Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
    Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells.
    Kasza A; Rogowski K; Kilarski W; Sobota R; Bernas T; Dobrucki J; Travis J; Koj A; Bugno M; Kordula T
    Biochem J; 2001 Apr; 355(Pt 2):307-14. PubMed ID: 11284716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
    Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
    J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.